IDIOPATHIC CONSTIPATION Clinical Trials

5 clinical trials for IDIOPATHIC CONSTIPATION across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• AN OPEN-LABEL EXTENSION (OLE), LONG-TERM SAFETY AND TOLERABILITY STUDY OF PLECANATIDE IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION (CIC) — RECRUITING
• A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE 3 TRIAL IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION TO DEMONSTRATE THE EFFICACY AND SAFETY OF ELOBIXIBAT 5 MG AND 10 MG FOR 26 WEEKS. — RECRUITING · PHASE3
• A MULTICENTER, OPEN-LABEL, SAFETY AND TOLERABILITY EXTENSION TRIAL OF 5 MG AND 10 MG ELOBIXIBAT DAILY IN THE TREATMENT OF CHRONIC IDIOPATHIC CONSTIPATION. — RECRUITING
• A RANDOMIZED, 12-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF PLECANATIDE (3.0 AND 6.0 MG) IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION (THE CIC3 STUDY) — COMPLETED
• A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE 3 TRIAL IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION TO DEMONSTRATE THE EFFICACY AND SAFETY OF ELOBIXIBAT 5 MG AND 10 MG FOR 12 WEEKS FOLLOWED BY A 4-WEEK WITHDRAWAL PERIOD. — NOT_YET_RECRUITING · PHASE3

Refine this search